Ras and relatives - Job sharing and networking keep an old family together

Experimental Hematology

Volumn 30, Issue 10, 2002, Pages 1089-1106

  Ehrhardt, Annette ^a   Ehrhardt, Götz R A ^b   Guo, Xuecui ^a   Schrader, John W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; ISOPROTEIN; RAS PROTEIN;

CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; CELL STIMULATION; ENZYME REGULATION; GROWTH INHIBITION; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MULTIGENE FAMILY; PHYLOGENY; RAS GTPASE-ACTIVATING PROTEINS; RAS PROTEINS;

CAENORHABDITIS; CAENORHABDITIS ELEGANS;

EID: 0036789949     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00904-9     Document Type: Review

References (241)

1. Harvey J.J. An unidentified virus which causes the rapid production of tumours in mice. Nature. 204:1964;1104.
2. Kirsten W.H., Mayer L.A. Morphologic responses to a murine erythroblastosis virus. J Natl Cancer Inst. 39:1967;311.
3. Lenzen C., Cool R.H., Prinz H., Kuhlmann J., Wittinghofer A. Kinetic analysis by fluorescence of the interaction between Ras and the catalytic domain of the guanine nucleotide exchange factor Cdc25Mm. Biochemistry. 37:1998;7420.
4. Boriack-Sjodin P.A., Margarit S.M., Bar-Sagi D., Kuriyan J. The structural basis of the activation of Ras by Sos. Nature. 394:1998;337.
5. Reuther G.W., Der C.J. The Ras branch of small GTPases. Ras family members don't fall far from the tree Curr Opin Cell Biol. 12:2000;157.
6. Casey P.J. Protein lipidation in cell signaling. Science. 268:1995;221.
7. Reuter C.W., Morgan M.A., Bergmann L. Targeting the Ras signaling pathway. a rational, mechanism-based treatment for hematologic malignancies? Blood. 96:2000;1655.
8. Hancock J.F., Paterson H., Marshall C.J. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell. 63:1990;133.
9. Hancock J.F., Magee A.I., Childs J.E., Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 57:1989;1167.
10. Choy E., Chiu V.K., Silletti J.et al. Endomembrane trafficking of ras. the CAAX motif targets proteins to the ER and Golgi Cell. 98:1999;69.
11. Apolloni A., Prior I.A., Lindsay M., Parton R.G., Hancock J.F. H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol. 20:2000;2475.
12. Thissen J.A., Gross J.M., Subramanian K., Meyer T., Casey P.J. Prenylation-dependent association of Ki-Ras with microtubules. Evidence for a role in subcellular trafficking. J Biol Chem. 272:1997;30362.
13. Roy S., Luetterforst R., Harding A.et al. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol. 1:1999;98.
14. Prior I.A., Harding A., Yan J.et al. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol. 3:2001;368.
15. Jaumot M., Yan J., Clyde-Smith J., Sluimer J., Hancock J.F. The linker domain of the H-Ras hypervariable region regulates interactions with exchange factors, Raf-1 and phosphoinositide 3-kinase. J Biol Chem. 31:2001;31.
16. Cheng P.C., Brown B.K., Song W., Pierce S.K. Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J Immunol. 166:2001;3693.
17. Xavier R., Brennan T., Li Q., McCormack C., Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity. 8:1998;723.
18. Sheets E.D., Holowka D., Baird B. Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol. 145:1999;877.
19. Simons K., Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 1:2000;31.
20. Lisanti M.P., Scherer P.E., Vidugiriene J.et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source. implications for human disease J Cell Biol. 126:1994;111.
21. Wei W., Mosteller R.D., Sanyal P.et al. Identification of a mammalian gene structurally and functionally related to the CDC25 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 89:1992;7100.
22. Cen H., Papageorge A.G., Zippel R., Lowy D.R., Zhang K. Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25. identification of a region related to Bcr, Vav, Dbl and CDC24 Embo J. 11:1992;4007.
23. Martegani E., Vanoni M., Zippel R.et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. Embo J. 11:1992;2151.
24. Fam N.P., Fan W.T., Wang Z.et al. Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras. Mol Cell Biol. 17:1997;1396.
25. Jones M.K., Jackson J.H. Ras-GRF activates Ha-Ras, but not N-Ras or K-Ras 4B, protein in vivo. J Biol Chem. 273:1998;1782.
26. Ohba Y., Mochizuki N., Yamashita S.et al. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3. J Biol Chem. 275:2000;20020.
27. Gotoh T., Tian X., Feig L.A. Prenylation of target gtpases contributes to signaling specificity of ras-guanine nucleotide exchange factors. J Biol Chem. 276:2001;38029.
28. de Hoog C.L., Fan W.T., Goldstein M.D., Moran M.F., Koch C.A. Calmodulin-independent coordination of Ras and extracellular signal-regulated kinase activation by Ras-GRF2. Mol Cell Biol. 20:2000;2727.
29. Bowtell D., Fu P., Simon M., Senior P. Identification of murine homologues of the Drosophila son of sevenless gene. potential activators of ras Proc Natl Acad Sci U S A. 89:1992;6511.
30. Chardin P., Camonis J.H., Gale N.W.et al. Human Sos1. a guanine nucleotide exchange factor for Ras that binds to GRB2 Science. 260:1993;1338.
31. Nielsen K.H., Gredsted L., Broach J.R., Willumsen B.M. Sensitivity of wild type and mutant ras alleles to Ras specific exchange factors. Identification of factor specific requirements Oncogene. 20:2001;2091.
32. Liu B.X., Wei W., Broek D. The catalytic domain of the mouse sos1 gene product activates Ras proteins in vivo and in vitro. Oncogene. 8:1993;3081.
33. Tognon C.E., Kirk H.E., Passmore L.A.et al. Regulation of RasGRP via a phorbol ester-responsive C1 domain. Mol Cell Biol. 18:1998;6995.
34. Clyde-Smith J., Silins G., Gartside M.et al. Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor. J Biol Chem. 275:2000;32260.
35. Yamashita S., Mochizuki N., Ohba Y.et al. CalDAG-GEFIII activation of Ras, R-ras, and Rap1. J Biol Chem. 275:2000;25488.
36. Kawasaki H., Springett G.M., Toki S.et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A. 95:1998;13278.
37. Lorenzo P.S., Kung J.W., Bottorff D.A.et al. Phorbol esters modulate the Ras exchange factor RasGRP3. Cancer Res. 61:2001;943.
38. Yang Y., Li L., Wong G.W.et al. RasGRP4, a new mast cell-restricted ras guanine nucleotide releasing protein with calcium- and diacylglycerol-binding motifs. Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients; and demonstration of the importance of RasGRP4 in mast cell development and function. J Biol Chem. 15:2002;15.
39. Reuther G.W., Lambert Q.T., Rebhun J.F.et al. RasGRP4 is a novel ras activator isolated from acute myeloid leukemia. J Biol Chem. 5:2002;5.
40. Kawasaki H., Springett G.M., Mochizuki N.et al. A family of cAMP-binding proteins that directly activate Rap1. Science. 282:1998;2275.
41. Rebhun J.F., Castro A.F., Quilliam L.A. Identification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. Regulation of MR-GEF by M-Ras-GTP interaction. J Biol Chem. 275:2000;34901.
42. Gao X., Satoh T., Liao Y.et al. Identification and characterization of RA-GEF-2, a Rap guanine nucleotide exchange factor that serves as a downstream target of M-Ras. J Biol Chem. 276:2001;42219.
43. Jin T.G., Satoh T., Liao Y.et al. Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling. J Biol Chem. 276:2001;30301.
44. Gotoh T., Cai D., Tian X., Feig L.A., Lerner A. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. J Biol Chem. 275:2000;30118.
45. Tanaka S., Morishita T., Hashimoto Y.et al. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A. 91:1994;3443.
46. Chiang S.H., Baumann C.A., Kanzaki M.et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature. 410:2001;944.
47. Kaibuchi K., Mizuno T., Fujioka H.et al. Molecular cloning of the cDNA for stimulatory GDP/GTP exchange protein for smg p21s (ras p21-like small GTP-binding proteins) and characterization of stimulatory GDP/GTP exchange protein. Mol Cell Biol. 11:1991;2873.
48. Takai Y., Kaibuchi K., Kikuchi A., Sasaki T., Shirataki H. Regulators of small GTPases. Ciba Found Symp. 176:1993;128.
49. Vikis H.G., Stewart S., Guan K.L. SmgGDS displays differential binding and exchange activity towards different Ras isoforms. Oncogene. 21:2002;2425.
50. Tian X., Feig L.A. Basis for Signaling Specificity Difference between Sos and Ras-GRF Guanine Nucleotide Exchange Factors. J Biol Chem. 276:2001;47248.
51. Ahmadian M.R., Stege P., Scheffzek K., Wittinghofer A. Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat Struct Biol. 4:1997;686.
52. Adari H., Lowy D.R., Willumsen B.M., Der C.J., McCormick F. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science. 240:1988;518.
53. Martin G.A., Yatani A., Clark R.et al. GAP domains responsible for ras p21-dependent inhibition of muscarinic atrial K+ channel currents. Science. 255:1992;192.
54. Medema R.H., de Laat W.L., Martin G.A., McCormick F., Bos J.L. GTPase-activating protein SH2-SH3 domains induce gene expression in a Ras-dependent fashion. Mol Cell Biol. 12:1992;3425.
55. Ellis C., Moran M., McCormick F., Pawson T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature. 343:1990;377.
56. Settleman J., Albright C.F., Foster L.C., Weinberg R.A. Association between GTPase activators for Rho and Ras families. Nature. 359:1992;153.
57. McGlade J., Brunkhorst B., Anderson D.et al. The N-terminal region of GAP regulates cytoskeletal structure and cell adhesion. Embo J. 12:1993;3073.
58. Druker B., Okuda K., Matulonis U.et al. Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood. 79:1992;2215.
59. Amrein K.E., Flint N., Panholzer B., Burn P. Ras GTPase-activating protein. a substrate and a potential binding protein of the protein-tyrosine kinase p56lck Proc Natl Acad Sci U S A. 89:1992;3343.
60. Xu G.F., O'Connell P., Viskochil D.et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 62:1990;599.
61. Maekawa M., Li S., Iwamatsu A.et al. A novel mammalian Ras GTPase-activating protein which has phospholipid-binding and Btk homology regions. Mol Cell Biol. 14:1994;6879.
62. Yamamoto T., Matsui T., Nakafuku M., Iwamatsu A., Kaibuchi K. A novel GTPase-activating protein for R-Ras. J Biol Chem. 270:1995;30557.
63. Baba H., Fuss B., Urano J.et al. GapIII, a new brain-enriched member of the GTPase-activating protein family. J Neurosci Res. 41:1995;846.
64. Wittinghofer A. Signal transduction via Ras. Biol Chem. 379:1998;933.
65. Jiang Y., Ma W., Wan Y.et al. The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature. 395:1998;808.
66. Albright C.F., Giddings B.W., Liu J., Vito M., Weinberg R.A. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. Embo J. 12:1993;339.
67. Spaargaren M., Bischoff J.R. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc Natl Acad Sci U S A. 91:1994;12609.
68. Kikuchi A., Demo S.D., Ye Z.H., Chen Y.W., Williams L.T. ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol. 14:1994;7483.
69. Wolthuis R.M., Bauer B., van't Veer L.J.et al. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene. 13:1996;353.
70. Shao H., Andres D.A. A novel RalGEF-like protein, RGL3, as a candidate effector for rit and Ras. J Biol Chem. 275:2000;26914.
71. Ehrhardt G.R., Korherr C., Wieler J.S., Knaus M., Schrader J.W. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth. Oncogene. 20:2001;188.
72. Rebhun J.F., Chen H., Quilliam L.A. Identification and characterization of a new family of guanine nucleotide exchange factors for the ras-related GTPase Ral. J Biol Chem. 275:2000;13406.
73. de Bruyn K.M., de Rooij J., Wolthuis R.M.et al. RalGEF2, a pleckstrin homology domain containing guanine nucleotide exchange factor for Ral. J Biol Chem. 275:2000;29761.
74. D'Adamo D.R., Novick S., Kahn J.M., Leonardi P., Pellicer A. rsc. a novel oncogene with structural and functional homology with the gene family of exchange factors for Ral Oncogene. 14:1997;1295.
75. Rosario M., Paterson H.F., Marshall C.J. Activation of the Ral and phosphatidylinositol 3[prime] kinase signaling pathways by the ras-related protein TC21. Mol Cell Biol. 21:2001;3750.
76. Murphy G.A., Graham S.M., Morita S.et al. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation. J Biol Chem. 11:2002;11.
77. Hofer F., Fields S., Schneider C., Martin G.S. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci U S A. 91:1994;11089.
78. Kelley G.G., Reks S.E., Ondrako J.M., Smrcka A.V. Phospholipase C(epsilon). a novel Ras effector Embo J. 20:2001;743.
79. Han L., Colicelli J. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Mol Cell Biol. 15:1995;1318.
80. Tall G.G., Barbieri M.A., Stahl P.D., Horazdovsky B.F. Ras-activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1. Dev Cell. 1:2001;73.
81. Vojtek A.B., Hollenberg S.M., Cooper J.A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 74:1993;205.
82. Zhang X.F., Settleman J., Kyriakis J.M.et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 364:1993;308.
83. Rizzo M.A., Shome K., Watkins S.C., Romero G. The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J Biol Chem. 275:2000;23911.
84. Voice J.K., Klemke R.L., Le A., Jackson J.H. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem. 274:1999;17164.
85. Marte B.M., Rodriguez-Viciana P., Wennstrom S., Warne P.H., Downward J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol. 7:1997;63.
86. Kimmelman A., Tolkacheva T., Lorenzi M.V., Osada M., Chan A.M. Identification and characterization of R-ras3. a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution Oncogene. 15:1997;2675.
87. Quilliam L.A., Castro A.F., Rogers-Graham K.S.et al. M-Ras/ R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J Biol Chem. 274:1999;23850.
88. Rosario M., Paterson H.F., Marshall C.J. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. Embo J. 18:1999;1270.
89. Graham S.M., Vojtek A.B., Huff S.Y.et al. TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol. 16:1996;6132.
90. Movilla N., Crespo P., Bustelo X.R. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene. 18:1999;5860.
91. Graham S.M., Cox A.D., Drivas G.et al. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol. 14:1994;4108.
92. York R.D., Yao H., Dillon T.et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 392:1998;622.
93. Lange-Carter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., Johnson G.L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 260:1993;315.
94. Xu S., Robbins D.J., Christerson L.B.et al. Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain. Proc Natl Acad Sci U S A. 93:1996;5291.
95. Lange-Carter C.A., Johnson G.L. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science. 265:1994;1458.
96. Russell M., Lange-Carter C.A., Johnson G.L. Direct interaction between Ras and the kinase domain of mitogen- activated protein kinase kinase kinase (MEKK1). J Biol Chem. 270:1995;11757.
97. Lee F.S., Peters R.T., Dang L.C., Maniatis T. MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta. Proc Natl Acad Sci U S A. 95:1998;9319.
98. Rodriguez-Viciana P., Warne P.H., Dhand R.et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527.
99. Katso R., Okkenhaug K., Ahmadi K.et al. Cellular function of phosphoinositide 3-kinases. implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol. 17:2001;615.
100. Yan J., Roy S., Apolloni A., Lane A., Hancock J.F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem. 273:1998;24052.
101. Kimmelman A.C., Osada M., Chan A.M. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Oncogene. 19:2000;2014.
102. Satoh T., Nakafuku M., Miyajima A., Kaziro Y. Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci U S A. 88:1991;3314.
103. Welham M.J., Bone H., Levings M.et al. Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem. 272:1997;1377.
104. Nimnual A.S., Yatsula B.A., Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science. 279:1998;560.
105. Han J., Luby-Phelps K., Das B.et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 279:1998;558.
106. Michiels F., Stam J.C., Hordijk P.L.et al. Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation. J Cell Biol. 137:1997;387.
107. Walsh A.B., Bar-Sagi D. Differential activation of the Rac pathway by Ha-Ras and K-Ras. J Biol Chem. 276:2001;15609.
108. Diaz-Meco M.T., Lozano J., Municio M.M.et al. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem. 269:1994;31706.
109. Uberall F., Hellbert K., Kampfer S.et al. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol. 144:1999;413.
110. Kampfer S., Windegger M., Hochholdinger F.et al. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J Biol Chem. 276:2001;42834.
111. Wang Y., Waldron R.T., Dhaka A.et al. The RAS effector RIN1 directly competes with RAF and is regulated by 14- 3-3 proteins. Mol Cell Biol. 22:2002;916.
112. Vavvas D., Li X., Avruch J., Zhang X.F. Identification of Nore1 as a potential Ras effector. J Biol Chem. 273:1998;5439.
113. Ortiz-Vega S., Khokhlatchev A., Nedwidek M.et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene. 21:2002;1381.
114. Khokhlatchev A., Rabizadeh S., Xavier R.et al. Identification of a novel ras-regulated proapoptotic pathway. Curr Biol. 12:2002;253.
115. Vos M.D., Ellis C.A., Bell A., Birrer M.J., Clark G.J. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem. 275:2000;35669.
116. Matsuo T., Takahashi K., Suzuki E., Yamamoto D. The Canoe protein is necessary in adherens junctions for development of ommatidial architecture in the Drosophila compound eye. Cell Tissue Res. 298:1999;397.
117. Boettner B., Govek E.E., Cross J., Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc Natl Acad Sci U S A. 97:2000;9064.
118. Villalonga P., Lopez-Alcala C., Bosch M.et al. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Mol Cell Biol. 21:2001;7345.
119. Ehrhardt G.R., Leslie K.B., Lee F., Wieler J.S., Schrader J.W. M-Ras, a widely expressed 29-kD homologue of p21 Ras. expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line Blood. 94:1999;2433.
120. Feig L.A. Tools of the trade. use of dominant-inhibitory mutants of Ras-family GTPases Nat Cell Biol. 1:1999;E25.
121. Mulcahy L.S., Smith M.R., Stacey D.W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature. 313:1985;241.
122. Duronio V., Welham M.J., Abraham S., Dryden P., Schrader J.W. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci U S A. 89:1992;1587.
123. Satoh T., Endo M., Nakafuku M.et al. Accumulation of p21ras. GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci U S A. 87:1990;7926.
124. Satoh T., Endo M., Nakafuku M., Nakamura S., Kaziro Y. Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A. 87:1990;5993.
125. Taylor S.J., Shalloway D. Cell cycle-dependent activation of Ras. Curr Biol. 6:1996;1621.
126. Swan K.A., Alberola-Ila J., Gross J.A.et al. Involvement of p21ras distinguishes positive and negative selection in thymocytes. Embo J. 14:1995;276.
127. Iritani B.M., Forbush K.A., Farrar M.A., Perlmutter R.M. Control of B cell development by Ras-mediated activation of Raf. Embo J. 16:1997;7019.
128. Umanoff H., Edelmann W., Pellicer A., Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci U S A. 92:1995;1709.
129. Esteban L.M., Vicario-Abejon C., Fernandez-Salguero P.et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol. 21:2001;1444.
130. Wolfman J.C., Wolfman A. Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem. 275:2000;19315.
131. Johnson L., Greenbaum D., Cichowski K.et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:1997;2468.
132. Koera K., Nakamura K., Nakao K.et al. K-ras is essential for the development of the mouse embryo. Oncogene. 15:1997;1151.
133. Pells S., Divjak M., Romanowski P.et al. Developmentally regulated expression of murine K-ras isoforms. Oncogene. 15:1997;1781.
134. Hariharan I.K., Carthew R.W., Rubin G.M. The Drosophila roughened mutation. activation of a rap homolog disrupts eye development and interferes with cell determination Cell. 67:1991;717.
135. Asha H., de Ruiter N.D., Wang M.G., Hariharan I.K. The Rap1 GTPase functions as a regulator of morphogenesis in vivo. Embo J. 18:1999;605.
136. Sawamoto K., Winge P., Koyama S.et al. The Drosophila Ral GTPase regulates developmental cell shape changes through the Jun NH(2)-terminal kinase pathway. J Cell Biol. 146:1999;361.
137. Feig L.A., Cooper G.M. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol. 8:1988;3235.
138. Dobrowolski S., Harter M., Stacey D.W. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol Cell Biol. 14:1994;5441.
139. Aktas H., Cai H., Cooper G.M. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol. 17:1997;3850.
140. Maher J., Baker D.A., Manning M., Dibb N.J., Roberts I.A. Evidence for cell-specific differences in transformation by N-, H- and K-ras. Oncogene. 11:1995;1639.
141. Crespo P., Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci. 57:2000;1613.
142. Pruitt K., Der C.J. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171:2001;1.
143. Sherr C.J. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol. 2:2001;731.
144. Kamijo T., Zindy F., Roussel M.F.et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649.
145. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593.
146. Woods D., Parry D., Cherwinski H.et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol. 17:1997;5598.
147. Sewing A., Wiseman B., Lloyd A.C., Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol. 17:1997;5588.
148. Delgado M.D., Vaque J.P., Arozarena I.et al. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism. Oncogene. 19:2000;783.
149. Schondorf T., Rutzel S., Andrack A.et al. Immunohistochemical analysis reveals a protective effect of H-ras expression mediated via apoptosis in node-negative breast cancer patients. Int J Oncol. 20:2002;273.
150. Hughes P.E., Renshaw M.W., Pfaff M.et al. Suppression of integrin activation. a novel function of a Ras/Raf- initiated MAP kinase pathway Cell. 88:1997;521.
151. Shibayama H., Anzai N., Braun S.E.et al. H-Ras is involved in the inside-out signaling pathway of interleukin-3-induced integrin activation. Blood. 93:1999;1540.
152. Zhang Z., Vuori K., Wang H., Reed J.C., Ruoslahti E. Integrin activation by R-ras. Cell. 85:1996;61.
153. Zou J.X., Liu Y., Pasquale E.B., Ruoslahti E. Activated SRC oncogene phosphorylates R-ras and suppresses integrin activity. J Biol Chem. 277:2002;1824.
154. Tsukamoto N., Hattori M., Yang H., Bos J.L., Minato N. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem. 274:1999;18463.
155. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. Embo J. 15:1996;810.
156. Cantor S.B., Urano T., Feig L.A. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol Cell Biol. 15:1995;4578.
157. Quaroni A., Paul E.C. Cytocentrin is a Ral-binding protein involved in the assembly and function of the mitotic apparatus. J Cell Sci. 112:1999;707.
158. Henry D.O., Moskalenko S.A., Kaur K.J.et al. Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. Mol Cell Biol. 20:2000;8084.
159. Jiang H., Luo J.Q., Urano T.et al. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature. 378:1995;409.
160. Luo J.Q., Liu X., Frankel P.et al. Functional association between Arf and RalA in active phospholipase D complex. Proc Natl Acad Sci U S A. 95:1998;3632.
161. Suzuki J., Yamazaki Y., Li G., Kaziro Y., Koide H. Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts. Mol Cell Biol. 20:2000;4658.
162. Nakashima S., Morinaka K., Koyama S.et al. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. Embo J. 18:1999;3629.
163. Goi T., Shipitsin M., Lu Z.et al. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. Embo J. 19:2000;623.
164. de Ruiter N.D., Wolthuis R.M., van Dam H., Burgering B.M., Bos J.L. Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway. Mol Cell Biol. 20:2000;8480.
165. Wolthuis R.M., Franke B., van Triest M.et al. Activation of the small GTPase Ral in platelets. Mol Cell Biol. 18:1998;2486.
166. Kitayama H., Matsuzaki T., Sugimoto Y., Ikawa Y., Noda M. Genetic analysis of the K-rev-1 transformation-suppressor gene. Environ Health Perspect. 93:1991;73.
167. Okada S., Matsuda M., Anafi M., Pawson T., Pessin J.E. Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes. Embo J. 17:1998;2554.
168. Cook S.J., Rubinfeld B., Albert I., McCormick F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. Embo J. 12:1993;3475.
169. Zwartkruis F.J., Wolthuis R.M., Nabben N.M., Franke B., Bos J.L. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. Embo J. 17:1998;5905.
170. Ohba Y., Mochizuki N., Matsuo K.et al. Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol. 20:2000;6074.
171. Alberola-Ila J., Forbush K.A., Seger R., Krebs E.G., Perlmutter R.M. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature. 373:1995;620.
172. Molina T.J., Kishihara K., Siderovski D.P.et al. Profound block in thymocyte development in mice lacking p56lck. Nature. 357:1992;161.
173. Pages G., Guerin S., Grall D.et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 286:1999;1374.
174. Dower N.A., Stang S.L., Bottorff D.A.et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat Immunol. 1:2000;317.
175. Sharp L.L., Schwarz D.A., Bott C.M., Marshall C.J., Hedrick S.M. The influence of the MAPK pathway on T cell lineage commitment. Immunity. 7:1997;609.
176. Puente L.G., Stone J.C., Ostergaard H.L. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells. potential role of additional diacylglycerol binding proteins J Immunol. 165:2000;6865.
177. Yamashita M., Kimura M., Kubo M.et al. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci U S A. 96:1999;1024.
178. Downward J., Graves J.D., Warne P.H., Rayter S., Cantrell D.A. Stimulation of p21ras upon T-cell activation. Nature. 346:1990;719.
179. Izquierdo M., Downward J., Graves J.D., Cantrell D.A. Role of protein kinase C in T-cell antigen receptor regulation of p21ras. evidence that two p21ras regulatory pathways coexist in T cells Mol Cell Biol. 12:1992;3305.
180. Ebinu J.O., Bottorff D.A., Chan E.Y.et al. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science. 280:1998;1082.
181. Altman A., Deckert M. The function of small GTPases in signaling by immune recognition and other leukocyte receptors. Adv Immunol. 72:1999;1.
182. Reedquist K.A., Bos J.L. Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem. 273:1998;4944.
183. + T cells. Science. 271:1996;1276.
184. Boussiotis V.A., Freeman G.J., Berezovskaya A., Barber D.L., Nadler L.M. Maintenance of human T cell anergy. blocking of IL-2 gene transcription by activated Rap1 Science. 278:1997;124.
185. Nagaoka H., Takahashi Y., Hayashi R.et al. Ras mediates effector pathways responsible for pre-B cell survival, which is essential for the developmental progression to the late pre-B cell stage. J Exp Med. 192:2000;171.
186. Shaw A.C., Swat W., Ferrini R., Davidson L., Alt F.W. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient pro-B lymphocytes. J Exp Med. 189:1999;123.
187. Harwood A.E., Cambier J.C. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21ras1. J Immunol. 151:1993;4513.
188. Saxton T.M., van Oostveen I., Bowtell D., Aebersold R., Gold M.R. B cell antigen receptor cross-linking induces phosphorylation of the p21ras oncoprotein activators SHC and mSOS1 as well as assembly of complexes containing SHC, GRB-2, mSOS1, and a 145-kDa tyrosine- phosphorylated protein. J Immunol. 153:1994;623.
189. Graziadei L., Riabowol K., Bar-Sagi D. Co-capping of ras proteins with surface immunoglobulins in B lymphocytes. Nature. 347:1990;396.
190. Cheng P.C., Dykstra M.L., Mitchell R.N., Pierce S.K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med. 190:1999;1549.
191. Hashimoto A., Okada H., Jiang A.et al. Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med. 188:1998;1287.
192. Tamir I., Stolpa J.C., Helgason C.D.et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Immunity. 12:2000;347.
193. Gulbins E., Brenner B., Schlottmann K.et al. Activation of the Ras signaling pathway by the CD40 receptor. J Immunol. 157:1996;2844.
194. Sutherland C.L., Heath A.W., Pelech S.L., Young P.R., Gold M.R. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. J Immunol. 157:1996;3381.
195. Healy J.I., Dolmetsch R.E., Timmerman L.A.et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity. 6:1997;419.
196. McLeod S.J., Ingham R.J., Bos J.L., Kurosaki T., Gold M.R. Activation of the Rap1 GTPase by the B cell antigen receptor. J Biol Chem. 273:1998;29218.
197. Lioubin M.N., Myles G.M., Carlberg K., Bowtell D., Rohrschneider L.R. Shc, Grb2, Sos1, and a 150-kilodalton tyrosine-phosphorylated protein form complexes with Fms in hematopoietic cells. Mol Cell Biol. 14:1994;5682.
198. Lee A.W., States D.J. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol Cell Biol. 20:2000;6779.
199. Jin D.I., Jameson S.B., Reddy M.A., Schenkman D., Ostrowski M.C. Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling. Mol Cell Biol. 15:1995;693.
200. Skorski T., Szczylik C., Ratajczak M.Z.et al. Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides. J Exp Med. 175:1992;743.
201. Mavilio F., Kreider B.L., Valtieri M.et al. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G). Oncogene. 4:1989;301.
202. Maher J., Baker D., Dibb N., Roberts I. Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner. Leukemia. 10:1996;83.
203. Hibi S., Lohler J., Friel J., Stocking C., Ostertag W. Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation arrested hematopoietic cells. Blood. 81:1993;1841.
204. Caron E., Self A.J., Hall A. The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inflammatory mediators. Curr Biol. 10:2000;974.
205. Self A.J., Caron E., Paterson H.F., Hall A. Analysis of R-Ras signalling pathways. J Cell Sci. 114:2001;1357.
206. Geng Y., Gulbins E., Altman A., Lotz M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci U S A. 91:1994;8602.
207. Guha M., O'Connell M.A., Pawlinski R.et al. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood. 98:2001;1429.
208. Chen G.J., Colombo L.L., Lopez M.C., Watson R.R. Reduction of tumor necrosis factor production by splenocytes from v-Ha- ras oncogene-bearing mice. Cancer Lett. 74:1993;147.
209. Delarue F.L., Taylor B.S., Sebti S.M. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells. Oncogene. 20:2001;6531.
210. Ingram D.A., Yang F.C., Travers J.B.et al. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med. 191:2000;181.
211. Hiatt K.K., Ingram D.A., Zhang Y., Bollag G., Clapp D.W. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells. J Biol Chem. 276:2001;7240.
212. Tsai F.Y., Orkin S.H. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 89:1997;3636.
213. Kitamura Y., Morii E., Jippo T., Ito A. mi-transcription factor as a regulator of mast cell differentiation. Int J Hematol. 71:2000;197.
214. Bar-Sagi D., Gomperts B.D. Stimulation of exocytotic degranulation by microinjection of the ras oncogene protein into rat mast cells. Oncogene. 3:1988;463.
215. Prieschl E.E., Pendl G.G., Harrer N.E., Baumruker T. p21ras links Fc epsilon RI to NF-AT family member in mast cells. The AP. 3-like(factor in this cell type is an NF-AT family member. J Immunol 155):1995;4963.
216. Turner H., Cantrell D.A. Distinct Ras effector pathways are involved in Fc epsilon R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells. J Exp Med. 185:1997;43.
217. Ishizuka T., Terada N., Gerwins P.et al. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc Natl Acad Sci U S A. 94:1997;6358.
218. Csonga R., Prieschl E.E., Jaksche D., Novotny V., Baumruker T. Common and distinct signaling pathways mediate the induction of TNF-alpha and IL-5 in IgE plus antigen-stimulated mast cells. J Immunol. 160:1998;273.
219. Kimata M., Inagaki N., Kato T.et al. Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol. 60:2000;589.
220. Price L.S., Norman J.C., Ridley A.J., Koffer A. The small GTPases Rac and Rho as regulators of secretion in mast cells. Curr Biol. 5:1995;68.
221. Matsumura I., Nakajima K., Wakao H.et al. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 18:1998;4282.
222. Matsumura I., Kawasaki A., Tanaka H.et al. Biologic significance of GATA-1 activities in Ras-mediated megakaryocytic differentiation of hematopoietic cell lines. Blood. 96:2000;2440.
223. Garcia J., de Gunzburg J., Eychene A., Gisselbrecht S., Porteu F. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways. Mol Cell Biol. 21:2001;2659.
224. Ge Y., Li Z.H., Marshall M.S., Broxmeyer H.E., Lu L. Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells. Blood Cells Mol Dis. 24:1998;124.
225. Kang C.D., Do I.R., Kim K.W.et al. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells. Exp Mol Med. 31:1999;76.
226. + cells. J Exp Med. 185:1997;1337.
227. Graf T., McNagny K., Brady G., Frampton J. Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent. Cell. 70:1992;201.
228. Pazdrak K., Schreiber D., Forsythe P., Justement L., Alam R. The intracellular signal transduction mechanism of interleukin 5 in eosinophils. the involvement of lyn tyrosine kinase and the Ras-Raf-1- MEK-microtubule-associated protein kinase pathway J Exp Med. 181:1995;1827.
229. Hall D.J., Cui J., Bates M.E.et al. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood. 98:2001;2014.
230. Scheele J.S., Ripple D., Lubbert M. The role of ras and other low molecular weight guanine nucleotide (GTP)- binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci. 57:2000;1950.
231. MacKenzie K.L., Dolnikov A., Millington M., Shounan Y., Symonds G. Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice. Blood. 93:1999;2043.
232. Hawley R.G., Fong A.Z., Ngan B.Y., Hawley T.S. Hematopoietic transforming potential of activated ras in chimeric mice. Oncogene. 11:1995;1113.
233. Zou X., Calame K. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J Biol Chem. 274:1999;18141.
234. Skorski T., Kanakaraj P., Ku D.H.et al. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl. implication for RAS-dependent Philadelphia chromosome positive cell growth J Exp Med. 179:1994;1855.
235. Puil L., Liu J., Gish G.et al. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. Embo J. 13:1994;764.
236. Pendergast A.M., Quilliam L.A., Cripe L.D.et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 75:1993;175.
237. Zou X., Rudchenko S., Wong K., Calame K. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:1997;654.
238. Skorski T., Bellacosa A., Nieborowska-Skorska M.et al. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. Embo J. 16:1997;6151.
239. Nieborowska-Skorska M., Wasik M.A., Slupianek A.et al. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med. 189:1999;1229.
240. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307.
241. Bollag G., Clapp D.W., Shih S.et al. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet. 12:1996;144.